In the BioHarmony Drug Report Database
Apadaz (benzhydrocodone) is a small molecule pharmaceutical. Benzhydrocodone was first approved as Apadaz on 2018-02-23. It is used to treat pain in the USA. Apadaz's patents are valid until 2031-02-22 (FDA).